Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common stock. The company’s ...

LOUISVILLE, Ky., Feb. 18, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (NASDAQ: LGMK) (the “Company”), a provider of personal emergency response systems, health communications devices, and technology for ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...

The Company also plans to change its Nasdaq ticker symbol to "FFAI" on March 10, 2025, and host an "FF Open AI Day" on March 17. The FF Open AI Day will showcase the Company's current and future AI ...

Aptose Biosciences (APTO) announced that its board of directors has approved, subject to required regulatory and stock exchange approvals, a ...

The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

Nexxen’s $50 million Ordinary Share repurchase program will continue on Nasdaq following the Company’s delisting from AIM and is currently expected to continue until May 19, 2025, or completion.

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

Additional information about the reverse stock split can be found in the Current Report on Form 8-K filed today and in the Company’s definitive proxy statement (Form DEF 14A) filed with the United ...

The Company intends to monitor the closing bid price of its Ordinary Shares and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement ...

These are the upcoming stock splits for the week of February 17 to February 21, based on TipRanks’ Stock Splits Calendar.